• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Get started
Sign in
Availability of millions of echocardiogram reports make Truveta the market leader in data for cardiovascular research

Availability of millions of echocardiogram reports make Truveta the market leader in data for cardiovascular research

by Michael Simonov, MD | Nov 8, 2023 | News, Technology

When I had the first conversations about creating Truveta, I knew technology was the answer to solving healthcare data challenges. Healthcare data traditionally has been too siloed, inaccessible, and messy to be useful for research. And one of the biggest challenges...
Moving from maternal health research to action

Moving from maternal health research to action

by Truveta Research | Aug 23, 2023 | Research, Research Insights

The United States has some of the highest rates of adverse maternal health outcomes compared to other high-income countries (Creanga et al., 2015; Gunja et al., 2022; Taylor et al., 2022). These outcomes have only increased in the last decade (Hoyert, 2023; U.S....
Real-time monitoring of prescription trends and demographics of two SGLT2i drugs

Real-time monitoring of prescription trends and demographics of two SGLT2i drugs

by Truveta Research | Jul 10, 2023 | Research, Research Insights

We explored the demographic characteristics of patients with type 2 diabetes mellitus, heart failure, and chronic kidney disease who received a prescription for empagliflozin (Jardiance) and/or dapagliflozin (Farxiga), two commonly used SGLT2i drugs. We saw...
LinkedIn Live: Truveta Research discusses recent maternal heart health study

LinkedIn Live: Truveta Research discusses recent maternal heart health study

by Truveta Staff | Feb 15, 2023 | News, Research

The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color more than white women. This February, in honor of Heart Health Month and Black History Month, Truveta...
Preeclampsia-related heart failure disproportionately impacts Black mothers

Preeclampsia-related heart failure disproportionately impacts Black mothers

by Truveta Research | Feb 7, 2023 | Research, Research Insights

Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women.  Maternal health outcomes in the US are worse than in many other high-income countries such as England, France,...

Share this


Recent posts

  • First real-world comparative effectiveness study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
  • Beyond claims data: Truveta showcases potential of EHR data at ISPOR EU 2023
  • Reflections from the inaugural Truveta Symposium

Follow Truveta


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.